According to Source BioScience, the acquisition is set to “complement” its genomics and multiomics capabilities, broadening ...

Colossal Biosciences has been chasing de-extinction since its founding in 2021, and with their latest discovery, they appear to have accomplished their task. The Dallas-based startup announced Monday ...

In addition to job gains, local leaders see Arizona emerging as one of the nation’s most dynamic hubs for bioscience ...

Scientists have disputed a bioscience firm’s claims to have resurrected the extinct dire wolf more than 10,000 years after ...

Skye Bioscience, Inc.’s SKYE share price has dipped by 12.88%, which has investors questioning if this is right time to buy.

Barclays lowered the firm’s price target on Twist Bioscience (TWST) to $45 from $58 and keeps an Overweight rating on the shares as part of a ...

Brookline Capital Management cut their Q1 2025 earnings per share estimates for shares of Daré Bioscience in a report issued ...

KeyBanc last night downgraded Harvard Bioscience (HBIO) to Sector Weight from Overweight without a price target Despite the successful launch ...

Daré Bioscience, Inc. (NASDAQ: DARE), a biopharmaceutical company driven by a mission to challenge the status quo, making women's health a priority, today reported financial results for the year ...

Equities researchers at HC Wainwright issued their FY2029 earnings estimates for shares of Daré Bioscience in a research note ...

Kanvas Biosciences’ new research suggests that the company’s HiPR-Map Platform is capable of outperforming traditional ...